FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5026511000001102: Bidor 5% tablets (Weleda (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18606101000001116 Bidor 5% tablets (Weleda (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18606201000001111 Bidor 5% tablets (Weleda (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bidor 5% tablets (Weleda (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Is a Ferrous sulphate 4mg / Silica 1.6mg tablets true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has active ingredient Skin agent false Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Is a Bidor true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has specific active ingredient Silica true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has specific active ingredient Ferrous sulfate true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has active ingredient Ferrous sulfate true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bidor 5% tablets (Weleda (UK) Ltd) 50 tablet Is pack of False Bidor 5% tablets (Weleda (UK) Ltd) Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) 100 tablet Is pack of False Bidor 5% tablets (Weleda (UK) Ltd) Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) 50 tablet Has AMP True Bidor 5% tablets (Weleda (UK) Ltd) Inferred relationship Existential restriction modifier
Bidor 5% tablets (Weleda (UK) Ltd) 100 tablet Has AMP True Bidor 5% tablets (Weleda (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start